...
首页> 外文期刊>Disease management and health outcomes >Impact of Three-Tier Pharmacy Benefit Structures on Consumer Attitudes, Pharmacy, Medical Utilization and Costs A Critical Review
【24h】

Impact of Three-Tier Pharmacy Benefit Structures on Consumer Attitudes, Pharmacy, Medical Utilization and Costs A Critical Review

机译:三层药房利益结构对消费者态度,药房,医疗利用率和成本的影响

获取原文
获取原文并翻译 | 示例

摘要

Three-tier pharmacy benefit plans are the dominant structure in prescription drug coverage today. In these plans three copayments exist. The lowest copayment is for generics, the middle copayment is for preferred brands and the highest copayment is for non-preferred brands. The premise of these plans is that by shifting the burden of cost onto the consumer, consumers will be more judicious in their prescription purchasing behavior. This review article outlines the empirical evidence regarding the utility of three-tier plans in changing consumer's prescription purchasing behavior.The results from a few key studies appear to suggest that three-tier plans reduce prescription drug spending for health plans while significantly increasing the cost-sharing amount for consumers. While the increased cost sharing created higher levels of dissatisfaction among three-tier plan members, it appears that they modify their behavior in accordance with these plans by switching to lower cost formulary alternatives. The factors that appeared to affect these behaviors included provider opinion and the comparability of the formulary and non-formulary alternatives. However, there are a myriad of factors that could influence the decision to switch from one drug to another (one example is switching for purely clinical reasons), and thus a clear link between the implementation of three-tier plans and switching behavior is hard to establish.What still remains unanswered is the impact of three-tier plans on vulnerable populations such as the elderly, low-income individuals and individuals with chronic disease who may be most adversely affected by the implementation of such policies. These individuals may discontinue or reduce appropriate utilization of their medications that could lead to adverse outcomes. Adequate follow-up for these vulnerable populations who are enrolled in a three-tier plan needs to be conducted to ensure appropriate medication use.
机译:三级药房福利计划是当今处方药承保范围的主要结构。在这些计划中,存在三种共付额。最低的共付额是仿制药,中间的共付额是首选品牌,最高的共付额是非首选品牌。这些计划的前提是,通过将成本负担转移给消费者,消费者将更加明智地购买处方药。这篇评论文章概述了有关三级计划在改变消费者处方购买行为中的效用的经验证据。一些关键研究的结果似乎表明,三级计划减少了健康计划的处方药支出,同时显着增加了成本,为消费者分摊金额。虽然增加的成本分担在三级计划成员中引起了更高的不满意程度,但他们似乎通过改用成本更低的配方替代品来根据这些计划修改其行为。似乎影响这些行为的因素包括提供者的意见以及配方和非常规替代品的可比性。但是,有很多因素可能会影响从一种药物转换为另一种药物的决定(一个例子是纯粹出于临床原因而进行转换),因此,很难实现三层计划的实施与转换行为之间的明确联系。仍然没有答案的是三级计划对脆弱人群的影响,例如老年人,低收入人群和患有慢性病的人群,这些人群可能会因实施此类政策而受到最不利的影响。这些人可能会中断或减少对药物的适当利用,这可能导致不良后果。需要对参加三级计划的这些弱势人群进行充分的随访,以确保适当的药物使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号